Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nuclear Physics | 6 | 2014 | 73 | 0.660 |
Why?
|
Elementary Particles | 4 | 2014 | 50 | 0.440 |
Why?
|
Myeloproliferative Disorders | 4 | 2015 | 614 | 0.430 |
Why?
|
Chromosome Aberrations | 4 | 2013 | 1780 | 0.410 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 2 | 2023 | 173 | 0.390 |
Why?
|
Decidua | 1 | 2011 | 82 | 0.360 |
Why?
|
Hormone Replacement Therapy | 1 | 2016 | 756 | 0.360 |
Why?
|
Abortion, Habitual | 1 | 2011 | 61 | 0.350 |
Why?
|
Cesarean Section, Repeat | 1 | 2009 | 29 | 0.320 |
Why?
|
Receptors, Progesterone | 1 | 2013 | 1145 | 0.310 |
Why?
|
Calreticulin | 3 | 2014 | 115 | 0.310 |
Why?
|
Thrombocythemia, Essential | 3 | 2014 | 114 | 0.310 |
Why?
|
Arsenic | 1 | 2012 | 362 | 0.300 |
Why?
|
Water Pollutants, Chemical | 1 | 2012 | 362 | 0.290 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 2024 | 3620 | 0.280 |
Why?
|
Models, Theoretical | 6 | 2014 | 3579 | 0.280 |
Why?
|
Receptors, Estrogen | 2 | 2022 | 2247 | 0.270 |
Why?
|
Placenta Diseases | 1 | 2009 | 199 | 0.270 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2011 | 526 | 0.270 |
Why?
|
Neuroblastoma | 4 | 2022 | 1265 | 0.250 |
Why?
|
Primary Myelofibrosis | 4 | 2014 | 209 | 0.240 |
Why?
|
Neoplasms, Second Primary | 1 | 2012 | 1060 | 0.230 |
Why?
|
Hypereosinophilic Syndrome | 2 | 2015 | 97 | 0.220 |
Why?
|
Elementary Particle Interactions | 2 | 2013 | 17 | 0.220 |
Why?
|
Janus Kinase 2 | 4 | 2014 | 561 | 0.210 |
Why?
|
Receptor, erbB-2 | 1 | 2013 | 2588 | 0.210 |
Why?
|
Barth Syndrome | 1 | 2022 | 25 | 0.200 |
Why?
|
Killer Cells, Natural | 1 | 2011 | 2207 | 0.190 |
Why?
|
Epigenesis, Genetic | 2 | 2022 | 3826 | 0.180 |
Why?
|
Acyltransferases | 1 | 2022 | 306 | 0.170 |
Why?
|
Registries | 2 | 2017 | 8378 | 0.170 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 384 | 0.170 |
Why?
|
Neutrophils | 2 | 2023 | 3785 | 0.170 |
Why?
|
Candidiasis | 1 | 2022 | 367 | 0.160 |
Why?
|
Toll-Like Receptors | 1 | 2022 | 582 | 0.150 |
Why?
|
Receptors, Thrombopoietin | 3 | 2013 | 160 | 0.140 |
Why?
|
DNA Replication | 1 | 2024 | 1429 | 0.140 |
Why?
|
Mesons | 2 | 2014 | 28 | 0.140 |
Why?
|
Neutropenia | 1 | 2022 | 893 | 0.140 |
Why?
|
Myositis Ossificans | 1 | 2017 | 77 | 0.140 |
Why?
|
Leukemia | 2 | 2022 | 1526 | 0.130 |
Why?
|
Oncogenes | 1 | 2022 | 1234 | 0.130 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2015 | 1614 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-cbl | 2 | 2013 | 120 | 0.130 |
Why?
|
DNA Modification Methylases | 1 | 2015 | 209 | 0.120 |
Why?
|
Ossification, Heterotopic | 1 | 2017 | 240 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2013 | 2846 | 0.120 |
Why?
|
Neutrons | 1 | 2014 | 78 | 0.110 |
Why?
|
Proteins | 2 | 2023 | 6006 | 0.110 |
Why?
|
DNA Repair Enzymes | 1 | 2015 | 346 | 0.110 |
Why?
|
Ovarian Neoplasms | 1 | 2011 | 4908 | 0.110 |
Why?
|
Genome | 1 | 2022 | 1747 | 0.110 |
Why?
|
Pyrazoles | 2 | 2015 | 2021 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 2 | 2015 | 2811 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2013 | 2911 | 0.100 |
Why?
|
Uniparental Disomy | 1 | 2012 | 46 | 0.100 |
Why?
|
Serbia | 1 | 2012 | 13 | 0.100 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2013 | 411 | 0.100 |
Why?
|
Ultrasonography, Prenatal | 2 | 2010 | 1767 | 0.100 |
Why?
|
Nucleotides | 2 | 2024 | 455 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 2 | 2013 | 4526 | 0.090 |
Why?
|
Water Supply | 1 | 2012 | 204 | 0.090 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2011 | 370 | 0.090 |
Why?
|
Multicystic Dysplastic Kidney | 1 | 2010 | 7 | 0.090 |
Why?
|
Karyotyping | 1 | 2012 | 1173 | 0.090 |
Why?
|
Dioxygenases | 1 | 2012 | 351 | 0.090 |
Why?
|
Loss of Heterozygosity | 1 | 2012 | 663 | 0.090 |
Why?
|
beta-Thalassemia | 1 | 2012 | 236 | 0.080 |
Why?
|
Kell Blood-Group System | 1 | 2009 | 21 | 0.080 |
Why?
|
Umbilical Arteries | 1 | 2010 | 77 | 0.080 |
Why?
|
Aromatase Inhibitors | 1 | 2013 | 519 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3666 | 0.080 |
Why?
|
Erythroblastosis, Fetal | 1 | 2009 | 62 | 0.080 |
Why?
|
Mutation | 4 | 2014 | 30230 | 0.080 |
Why?
|
Cytomegalovirus | 1 | 2013 | 754 | 0.080 |
Why?
|
Blood Group Incompatibility | 1 | 2009 | 134 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2015 | 8628 | 0.080 |
Why?
|
Diagnostic Imaging | 1 | 2022 | 3541 | 0.080 |
Why?
|
Cell Cycle | 2 | 2013 | 2934 | 0.080 |
Why?
|
Humans | 32 | 2024 | 768298 | 0.080 |
Why?
|
Menopause | 1 | 2016 | 1653 | 0.070 |
Why?
|
Mice | 11 | 2024 | 82004 | 0.070 |
Why?
|
RNA Splicing | 1 | 2012 | 903 | 0.070 |
Why?
|
Abruptio Placentae | 1 | 2009 | 118 | 0.070 |
Why?
|
Hedgehog Proteins | 1 | 2012 | 770 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 12239 | 0.070 |
Why?
|
Protons | 1 | 2013 | 1112 | 0.070 |
Why?
|
Placenta Previa | 1 | 2009 | 126 | 0.070 |
Why?
|
Fagopyrum | 1 | 2006 | 1 | 0.070 |
Why?
|
DNA-Binding Proteins | 3 | 2013 | 9618 | 0.070 |
Why?
|
Genes, Tumor Suppressor | 1 | 2011 | 1064 | 0.070 |
Why?
|
Signal Transduction | 3 | 2024 | 23629 | 0.070 |
Why?
|
Pregnancy | 6 | 2011 | 30198 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3794 | 0.070 |
Why?
|
Chromosome Deletion | 1 | 2011 | 1390 | 0.070 |
Why?
|
Cytomegalovirus Infections | 1 | 2013 | 839 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3242 | 0.070 |
Why?
|
Cell Differentiation | 1 | 2024 | 11659 | 0.070 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2012 | 954 | 0.070 |
Why?
|
Breast Neoplasms | 1 | 2013 | 21163 | 0.060 |
Why?
|
Fertility | 1 | 2011 | 772 | 0.060 |
Why?
|
Fetal Growth Retardation | 1 | 2010 | 591 | 0.060 |
Why?
|
Neoplasm Proteins | 2 | 2022 | 3609 | 0.060 |
Why?
|
Female | 18 | 2021 | 397050 | 0.060 |
Why?
|
Placenta Accreta | 1 | 2009 | 241 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6541 | 0.060 |
Why?
|
Myelodysplastic Syndromes | 2 | 2013 | 1399 | 0.060 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2013 | 1536 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2012 | 1248 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2020 | 5335 | 0.060 |
Why?
|
Gene Regulatory Networks | 1 | 2013 | 1753 | 0.060 |
Why?
|
Repressor Proteins | 2 | 2012 | 2986 | 0.060 |
Why?
|
Transcription Factors | 4 | 2022 | 12166 | 0.060 |
Why?
|
Exons | 3 | 2014 | 2392 | 0.060 |
Why?
|
Animals | 11 | 2024 | 169322 | 0.050 |
Why?
|
S Phase | 1 | 2024 | 423 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2889 | 0.050 |
Why?
|
Cardiolipins | 1 | 2022 | 83 | 0.050 |
Why?
|
Apoptosis | 2 | 2022 | 9506 | 0.050 |
Why?
|
Polycythemia Vera | 2 | 2013 | 160 | 0.050 |
Why?
|
Disease Progression | 3 | 2017 | 13646 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 3457 | 0.050 |
Why?
|
Partial Pressure | 1 | 2021 | 248 | 0.050 |
Why?
|
Ultraviolet Rays | 1 | 2006 | 1100 | 0.050 |
Why?
|
Cell Degranulation | 1 | 2022 | 277 | 0.050 |
Why?
|
Gases | 1 | 2021 | 204 | 0.050 |
Why?
|
Oxidoreductases | 1 | 2023 | 412 | 0.050 |
Why?
|
Mice, Congenic | 1 | 2020 | 98 | 0.040 |
Why?
|
Gene Expression Profiling | 2 | 2015 | 9508 | 0.040 |
Why?
|
Cell Line, Tumor | 2 | 2013 | 17132 | 0.040 |
Why?
|
Histone Acetyltransferases | 1 | 2022 | 335 | 0.040 |
Why?
|
Gene Library | 1 | 2022 | 1061 | 0.040 |
Why?
|
Prognosis | 3 | 2022 | 30020 | 0.040 |
Why?
|
Leukemia, Myeloid | 2 | 2013 | 693 | 0.040 |
Why?
|
Nitriles | 2 | 2015 | 984 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4414 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12092 | 0.040 |
Why?
|
Candida albicans | 1 | 2022 | 375 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7453 | 0.040 |
Why?
|
Antioxidants | 1 | 2006 | 1673 | 0.040 |
Why?
|
Cell Count | 1 | 2022 | 1833 | 0.040 |
Why?
|
DNA | 1 | 2012 | 7211 | 0.040 |
Why?
|
Transgenes | 1 | 2022 | 1015 | 0.040 |
Why?
|
Remission Induction | 2 | 2015 | 2407 | 0.040 |
Why?
|
Nuclear Proteins | 3 | 2022 | 5802 | 0.040 |
Why?
|
Pyrimidines | 3 | 2015 | 3048 | 0.040 |
Why?
|
Animals, Genetically Modified | 1 | 2022 | 1563 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13696 | 0.030 |
Why?
|
Base Sequence | 2 | 2022 | 12421 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2012 | 10464 | 0.030 |
Why?
|
Mice, Nude | 2 | 2013 | 3630 | 0.030 |
Why?
|
Phagocytosis | 1 | 2022 | 1530 | 0.030 |
Why?
|
Glucose-6-Phosphate Isomerase | 1 | 2015 | 49 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1839 | 0.030 |
Why?
|
Benzeneacetamides | 1 | 2015 | 36 | 0.030 |
Why?
|
Pyrans | 1 | 2015 | 49 | 0.030 |
Why?
|
Cell Lineage | 1 | 2024 | 2574 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2038 | 0.030 |
Why?
|
Adult | 7 | 2017 | 223622 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2013 | 6084 | 0.030 |
Why?
|
Aged | 6 | 2021 | 171544 | 0.030 |
Why?
|
Thrombocytosis | 1 | 2013 | 88 | 0.030 |
Why?
|
Vincristine | 1 | 2015 | 1040 | 0.030 |
Why?
|
Veratrum Alkaloids | 1 | 2012 | 23 | 0.030 |
Why?
|
Sulfones | 1 | 2015 | 448 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2023 | 3722 | 0.030 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2015 | 295 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 12775 | 0.030 |
Why?
|
Electrons | 1 | 2014 | 264 | 0.030 |
Why?
|
Ganciclovir | 1 | 2013 | 256 | 0.030 |
Why?
|
Dacarbazine | 1 | 2015 | 560 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 16027 | 0.030 |
Why?
|
Thermodynamics | 1 | 2014 | 590 | 0.030 |
Why?
|
Immunoblotting | 1 | 2015 | 1647 | 0.030 |
Why?
|
Pyridines | 2 | 2015 | 2889 | 0.020 |
Why?
|
Camptothecin | 1 | 2015 | 593 | 0.020 |
Why?
|
Codon | 1 | 2013 | 599 | 0.020 |
Why?
|
Janus Kinases | 1 | 2013 | 253 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2017 | 0.020 |
Why?
|
Granulocytes | 1 | 2013 | 549 | 0.020 |
Why?
|
Bone Marrow Diseases | 1 | 2013 | 234 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2013 | 4774 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2015 | 724 | 0.020 |
Why?
|
Luciferases | 1 | 2012 | 712 | 0.020 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2013 | 308 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 26373 | 0.020 |
Why?
|
beta Catenin | 1 | 2015 | 1047 | 0.020 |
Why?
|
Medulloblastoma | 1 | 2015 | 682 | 0.020 |
Why?
|
Triazoles | 1 | 2015 | 904 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2021 | 2754 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2967 | 0.020 |
Why?
|
Fetal Monitoring | 1 | 2010 | 70 | 0.020 |
Why?
|
Oxygen | 1 | 2021 | 4273 | 0.020 |
Why?
|
Pyrazines | 1 | 2015 | 1206 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2022 | 3079 | 0.020 |
Why?
|
Thrombosis | 2 | 2013 | 2955 | 0.020 |
Why?
|
Cisplatin | 1 | 2015 | 1661 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3940 | 0.020 |
Why?
|
Male | 7 | 2021 | 364870 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2022 | 9563 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2013 | 697 | 0.020 |
Why?
|
Doxorubicin | 1 | 2015 | 2229 | 0.020 |
Why?
|
Random Allocation | 1 | 2013 | 2397 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2012 | 718 | 0.020 |
Why?
|
Middle Aged | 4 | 2021 | 223463 | 0.020 |
Why?
|
Genotype | 2 | 2014 | 13038 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2013 | 1139 | 0.020 |
Why?
|
Gene Amplification | 1 | 2012 | 1090 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2023 | 14481 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2010 | 463 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2013 | 1395 | 0.020 |
Why?
|
DNA, Plant | 1 | 2006 | 52 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2013 | 26410 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 22389 | 0.020 |
Why?
|
Anxiety | 1 | 2021 | 4675 | 0.020 |
Why?
|
Catalase | 1 | 2006 | 216 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2010 | 1502 | 0.020 |
Why?
|
Plant Leaves | 1 | 2006 | 153 | 0.020 |
Why?
|
Pedigree | 1 | 2014 | 4545 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10266 | 0.020 |
Why?
|
Lipid Peroxidation | 1 | 2006 | 276 | 0.020 |
Why?
|
Glycoproteins | 1 | 2013 | 2204 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4120 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4584 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2015 | 5898 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5033 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3616 | 0.010 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 596 | 0.010 |
Why?
|
Young Adult | 3 | 2017 | 60048 | 0.010 |
Why?
|
Peroxidase | 1 | 2006 | 609 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2011 | 4622 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3436 | 0.010 |
Why?
|
Infant | 2 | 2017 | 36512 | 0.010 |
Why?
|
Antigens, CD | 1 | 2013 | 4031 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2022 | 18358 | 0.010 |
Why?
|
Alleles | 1 | 2013 | 6892 | 0.010 |
Why?
|
Child, Preschool | 2 | 2017 | 42654 | 0.010 |
Why?
|
Adolescent | 3 | 2017 | 89182 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11117 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2013 | 2236 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22355 | 0.010 |
Why?
|
Peptides | 1 | 2013 | 4352 | 0.010 |
Why?
|
Acute Disease | 1 | 2011 | 7242 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2013 | 3064 | 0.010 |
Why?
|
Glioma | 1 | 2015 | 3526 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 13499 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17626 | 0.010 |
Why?
|
Cell Line | 1 | 2013 | 15593 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 12557 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2011 | 4940 | 0.010 |
Why?
|
Chronic Disease | 1 | 2013 | 9380 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12801 | 0.010 |
Why?
|
Child | 2 | 2017 | 80894 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54921 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15868 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16716 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6969 | 0.010 |
Why?
|
Kidney | 1 | 2010 | 7063 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2015 | 9197 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 18047 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2015 | 65365 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2013 | 59683 | 0.000 |
Why?
|